Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (3-iodo-(131i)benzyl)guanidine
2. 123i Labeled 3-iodobenzylguanidine
3. 125i Labeled 3-iodobenzylguanidine
4. 3 Iodobenzylguanidine
5. 3 Iodobenzylguanidine, 123i Labeled
6. 3 Iodobenzylguanidine, 125i Labeled
7. 3-iodobenzylguanidine
8. 3-iodobenzylguanidine, 123i Labeled
9. 3-iodobenzylguanidine, 125i Labeled
10. Iobenguane
11. M Iodobenzylguanidine
12. M-iodobenzylguanidine
13. Meta Iodobenzylguanidine
14. Meta-iodobenzylguanidine
15. Mibg
1. Iobenguane I 131
2. 77679-27-7
3. 131i-mibg
4. Azedra
5. Iobenguane I-131
6. I-131 Metaiodobenzylguanidine
7. Metaiodobenzylguanidine I-131
8. I-131 Mibg
9. 3-iodobenzylguanidine (131i)
10. Iobenguane, I-131
11. 131 I-mibg
12. Iobenguane (131 I)
13. Mibg I-131
14. (131i)-mibg
15. Iodine (131i) Iobenguane
16. (m-((sup 131)i)iodobenzyl)guanidine
17. (m-iodo-(sup 131)i-benzyl)guanidine
18. Iobenguane (131i) [inn]
19. 3-iodobenzylguanidine, I-131
20. Q461l7ak4r
21. Guanidine, ((3-(iodo-(sup 131)i)phenyl)methyl)-
22. 1-(3-(iodo-131i)benzyl)guanidine
23. Iobeguane I 131
24. M131ibg
25. 3-iodobenzylguanidine (131i) (jan)
26. Iobenguane I131
27. Azedra (tn)
28. 3-iodobenzylguanidine (131i) [jan]
29. Iobenguano (131 I) [spanish]
30. Iobenguano (131 I)
31. Iobenguanum (131 I)
32. Ultratrace Iobenguane I131
33. Unii-q461l7ak4r
34. Iobenguane I 131 [usan]
35. Ultratrace Mibg
36. Iobenguanum (131 I) [latin]
37. Mibg-(131 I)
38. Iobenguane I 131 [usan:usp]
39. Iobenguane[131i]
40. Mibg[radioiodinated]
41. Starbld0007052
42. Myomibg-123i Injection
43. 131i-m-iodobenzylguanidine
44. Ultratrace Iobenguane 131i
45. Pheo Mibg-131i Injection
46. [131i]mibg
47. Iobenguane I 131 (usp)
48. Iobenguane ((sup 131)i)
49. Pheomibg-i 131 (tn)
50. Pheomibg-i(131) Injection
51. Chembl1615779
52. Meta-iodobenzylguanidine (mibg) Labeled With Iodine-131
53. Schembl13092741
54. Dtxsid30228311
55. I-131 Meta-iodobenzyl Guanidine
56. Chebi:135997
57. Moli000967
58. Iobenguane (131 I) [who-dd]
59. Iobenguane I-131 [orange Book]
60. Iobenguane I 131 [usp Impurity]
61. M-[123i/125i/131i]mibg
62. Guanidine, ((3-iodo-131i)phenyl)methyl)-
63. 2-[(3-(131i)iodanylphenyl)methyl]guanidine
64. Cold Contaminant-free Iobenguane I-131
65. D03308
66. Q27286979
67. Ultratrace Iodine I 131 Metaiodobenzylguanidine
Molecular Weight | 279.09 g/mol |
---|---|
Molecular Formula | C8H10IN3 |
XLogP3 | 1 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 1 |
Rotatable Bond Count | 2 |
Exact Mass | 278.993599 g/mol |
Monoisotopic Mass | 278.993599 g/mol |
Topological Polar Surface Area | 64.4 Ų |
Heavy Atom Count | 12 |
Formal Charge | 0 |
Complexity | 166 |
Isotope Atom Count | 1 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Antineoplastic Agents
Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)
Enzyme Inhibitors
Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)
Radiopharmaceuticals
Compounds that are used in medicine as sources of radiation for radiotherapy and for diagnostic purposes. They have numerous uses in research and industry. (Martindale, The Extra Pharmacopoeia, 30th ed, p1161) (See all compounds classified as Radiopharmaceuticals.)
V - Various
V09 - Diagnostic radiopharmaceuticals
V09I - Tumour detection
V09IX - Other diagnostic radiopharmaceuticals for tumour detection
V09IX02 - Iobenguane (131I)
V - Various
V10 - Therapeutic radiopharmaceuticals
V10X - Other therapeutic radiopharmaceuticals
V10XA - Iodine (131i) compounds
V10XA02 - Iobenguane (131I)
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
A Iobenguane I 131 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Iobenguane I 131, including repackagers and relabelers. The FDA regulates Iobenguane I 131 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Iobenguane I 131 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Iobenguane I 131 supplier is an individual or a company that provides Iobenguane I 131 active pharmaceutical ingredient (API) or Iobenguane I 131 finished formulations upon request. The Iobenguane I 131 suppliers may include Iobenguane I 131 API manufacturers, exporters, distributors and traders.
Iobenguane I 131 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Iobenguane I 131 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Iobenguane I 131 GMP manufacturer or Iobenguane I 131 GMP API supplier for your needs.
A Iobenguane I 131 CoA (Certificate of Analysis) is a formal document that attests to Iobenguane I 131's compliance with Iobenguane I 131 specifications and serves as a tool for batch-level quality control.
Iobenguane I 131 CoA mostly includes findings from lab analyses of a specific batch. For each Iobenguane I 131 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Iobenguane I 131 may be tested according to a variety of international standards, such as European Pharmacopoeia (Iobenguane I 131 EP), Iobenguane I 131 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Iobenguane I 131 USP).
LOOKING FOR A SUPPLIER?